Investor Sues Boston Scientific Over FDA's Mesh Product Pull
An investor sued Boston Scientific on Wednesday over the 7.7% drop in share price that followed the U.S. Food and Drug Administration's decision last week to pull the company's surgical mesh...To view the full article, register now.
Already a subscriber? Click here to view full article